Biochemical selection on conserved glycans yield a cross-species AAV capsid for efficient panretinal intravitreal delivery
Inherited retinal diseases are leading candidates for gene therapy, but photoreceptor-directed adeno-associated virus (AAV) vectors still require subretinal injection, which treats only part of the retina and carries surgical risk. Intravitreal delivery is simple and panretinal, yet inner-retinal barriers block most capsids, and capsids selected in one species rarely translate. Mapping retinal…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.